Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahrong Ham

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancers|August 26, 2023
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung CancerAhrong Ham, Young Lee, Hae Su Kim, et al.
Medicine|June 3, 2020
Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case reportJi Yun Bae, Ahrong Ham, Hee Jung Choi, et al.
Oncology Letters|November 29, 2023
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case reportSangik Noh, Ahrong Ham, Je Ryung Gil, et al.
Medicine|September 15, 2022
New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case reportJe Hyun Seo, Taekyu Lim, Ahrong Ham, et al.
Oncology Reports|June 3, 2022
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cellsAhrong Ham, Min Hee Cho, Hye Sung Won, et al.
Biochemical and Biophysical Research Communications|December 25, 2012
Functional characterization of genetic variations in the MDR3 promoterGeun Hye Jang, Tae Hee Kim, Yunseo Choe, et al.
Breast Cancer Research and Treatment|July 15, 2020
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Breast Cancer Research and Treatment|June 25, 2020
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Cancers|May 27, 2026
Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast CancerEsther Kim, Youra Lim, Ahrong Ham, et al.
Frontiers in Oncology|February 4, 2021
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score AnalysisJii Bum Lee, Han Sang Kim, Ahrong Ham, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancers|August 26, 2023
Real-World Outcomes of Nivolumab, Pembrolizumab, and Atezolizumab Treatment Efficacy in Korean Veterans with Stage IV Non-Small-Cell Lung CancerAhrong Ham, Young Lee, Hae Su Kim, et al.
Medicine|June 3, 2020
Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case reportJi Yun Bae, Ahrong Ham, Hee Jung Choi, et al.
Oncology Letters|November 29, 2023
Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case reportSangik Noh, Ahrong Ham, Je Ryung Gil, et al.
Medicine|September 15, 2022
New-onset type 1 diabetes mellitus as a delayed immune-related event after discontinuation of nivolumab: A case reportJe Hyun Seo, Taekyu Lim, Ahrong Ham, et al.
Oncology Reports|June 3, 2022
β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cellsAhrong Ham, Min Hee Cho, Hye Sung Won, et al.
Biochemical and Biophysical Research Communications|December 25, 2012
Functional characterization of genetic variations in the MDR3 promoterGeun Hye Jang, Tae Hee Kim, Yunseo Choe, et al.
Breast Cancer Research and Treatment|July 15, 2020
Correction to: Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Breast Cancer Research and Treatment|June 25, 2020
Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancerAhrong Ham, Min Hwan Kim, Gun Min Kim, et al.
Cancers|May 27, 2026
Analysis of the Frequency and Associated Factors of Skin Toxicity in Patients Receiving Ribociclib-Based Therapy for Metastatic Breast CancerEsther Kim, Youra Lim, Ahrong Ham, et al.
Frontiers in Oncology|February 4, 2021
Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score AnalysisJii Bum Lee, Han Sang Kim, Ahrong Ham, et al.
Pageof 1